Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

Skylark Bio has dosed the first patient in a Phase [...]

Genespire and researchers at the San Raffaele Telethon Institute for [...]

Cyllene Therapeutics has raised €33 million in a Series C [...]

Scribe Therapeutics has achieved a second success milestone in its [...]

nChroma Bio has presented new preclinical data supporting its lead [...]

Funding will support clinical development of SB-007 and expand pipeline [...]